| Application no. and date | 11734043.0 (espacenet) (Federated) (European Patent Register), 20110629 | | Patent/reg. no. and date | DK/EP 2588086, 20180912 | | Publication date | 20130508 | | Priority no. and date | EP 10168028, 20100630 | | EP pub. no. and date |
EP 2588086 20130508 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | T5864_DK | | Inventor | THAKUR, Jeewan, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
QIU, Zhihui, YuShan Lu 100 Nong Bldg 28-1901
PuDong New District
Shanghai 200135, CN | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) | | Title | FARMACEUTISKE SAMMENSÆTNINGER, DER OMFATTER 4-AMINO-5-FLUOR-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ON-LACTAT-MONOHYDRAT | | Int. application no. | EP2011060949 | | Int. publication no. | WO2012001074 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
